Alzheimer’s disease (AD) is a complex neurodegenerative disease that leads to insidious deterioration of brain functions. Current treatments for AD that focus on inhibition of amyloid beta (Aβ) aggregation failed to show effectiveness in people with AD symptoms.
Click here for original story, Researchers develop blood-brain-barrier-permeable nanoparticles for Alzheimer’s disease treatment
Source: Phys.org